{"transactions":[{"id":730674,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-22T20:29:31.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":49579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":49579,"derivative":{"exercise_price":1.13,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":49579},"source":{"system":"sec-edgar","filing":"0000905148-26-003056","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000090514826003056/form4.xml","form_type":"4"}},{"id":730673,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T20:29:31.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":30421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":201581,"source":{"system":"sec-edgar","filing":"0000905148-26-003056","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000090514826003056/form4.xml","form_type":"4"}},{"id":1103988,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T22:48:05.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":50790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":50790,"derivative":{"exercise_price":2.11,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":50790},"source":{"system":"sec-edgar","filing":"0000905148-25-002235","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000090514825002235/form4.xml","form_type":"4"}},{"id":1103987,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-23T22:48:05.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":29210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":171160,"source":{"system":"sec-edgar","filing":"0000905148-25-002235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000090514825002235/form4.xml","form_type":"4"}},{"id":1291954,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-29T21:13:11.000Z","date":"2025-01-27","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":17417,"derivative":{"exercise_price":2.932,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-25-002263","document":"form4-01292025_090107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588925002263/form4-01292025_090107.xml","form_type":"4"}},{"id":1291953,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-29T21:13:11.000Z","date":"2025-01-27","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":4.645,"value":13935.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.52 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":141950,"source":{"system":"sec-edgar","filing":"0001415889-25-002263","document":"form4-01292025_090107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588925002263/form4-01292025_090107.xml","form_type":"4"}},{"id":1291952,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-29T21:13:11.000Z","date":"2025-01-27","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":2.932,"value":8796.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."}],"balance_after":144950,"source":{"system":"sec-edgar","filing":"0001415889-25-002263","document":"form4-01292025_090107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588925002263/form4-01292025_090107.xml","form_type":"4"}},{"id":1320471,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-30T21:15:04.000Z","date":"2024-12-26","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":20417,"derivative":{"exercise_price":2.932,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-24-030230","document":"form4-12302024_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924030230/form4-12302024_041201.xml","form_type":"4"}},{"id":1320470,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-30T21:15:04.000Z","date":"2024-12-26","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":4.007,"value":12021.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.995 to $4.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":141950,"source":{"system":"sec-edgar","filing":"0001415889-24-030230","document":"form4-12302024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924030230/form4-12302024_041201.xml","form_type":"4"}},{"id":1320469,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-30T21:15:04.000Z","date":"2024-12-26","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":2.932,"value":8796.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."}],"balance_after":144950,"source":{"system":"sec-edgar","filing":"0001415889-24-030230","document":"form4-12302024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924030230/form4-12302024_041201.xml","form_type":"4"}},{"id":1337399,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-10T21:30:09.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":false,"shares":483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":23417,"derivative":{"exercise_price":2.932,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":483},"source":{"system":"sec-edgar","filing":"0001415889-24-028839","document":"form4-12102024_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924028839/form4-12102024_041201.xml","form_type":"4"}},{"id":1337398,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-10T21:30:09.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":false,"shares":1121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":1121},"source":{"system":"sec-edgar","filing":"0001415889-24-028839","document":"form4-12102024_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924028839/form4-12102024_041201.xml","form_type":"4"}},{"id":1337397,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-10T21:30:09.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":false,"shares":891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.926,"expiration_date":"2027-07-14","underlying":"Common Stock","underlying_shares":891},"source":{"system":"sec-edgar","filing":"0001415889-24-028839","document":"form4-12102024_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924028839/form4-12102024_041201.xml","form_type":"4"}},{"id":1337396,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-10T21:30:09.000Z","date":"2024-12-06","kind":"exercise","planned":true,"acquired":false,"shares":505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":891,"derivative":{"exercise_price":2.926,"expiration_date":"2027-07-14","underlying":"Common Stock","underlying_shares":505},"source":{"system":"sec-edgar","filing":"0001415889-24-028839","document":"form4-12102024_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924028839/form4-12102024_041201.xml","form_type":"4"}},{"id":1337395,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-10T21:30:09.000Z","date":"2024-12-09","kind":"sale","planned":true,"acquired":false,"shares":2495,"price":3.791,"value":9458.545,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.705 to $3.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":141950,"source":{"system":"sec-edgar","filing":"0001415889-24-028839","document":"form4-12102024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924028839/form4-12102024_041201.xml","form_type":"4"}},{"id":1337394,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-10T21:30:09.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":true,"shares":483,"price":2.932,"value":1416.156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."}],"balance_after":144445,"source":{"system":"sec-edgar","filing":"0001415889-24-028839","document":"form4-12102024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924028839/form4-12102024_041201.xml","form_type":"4"}},{"id":1337393,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-10T21:30:09.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":true,"shares":1121,"price":1.641,"value":1839.561,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."}],"balance_after":143962,"source":{"system":"sec-edgar","filing":"0001415889-24-028839","document":"form4-12102024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924028839/form4-12102024_041201.xml","form_type":"4"}},{"id":1337392,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-10T21:30:09.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":true,"shares":891,"price":2.926,"value":2607.066,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."}],"balance_after":142841,"source":{"system":"sec-edgar","filing":"0001415889-24-028839","document":"form4-12102024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924028839/form4-12102024_041201.xml","form_type":"4"}},{"id":1337391,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-10T21:30:09.000Z","date":"2024-12-06","kind":"sale","planned":true,"acquired":false,"shares":505,"price":3.701,"value":1869.005,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.70 to $3.705, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":141950,"source":{"system":"sec-edgar","filing":"0001415889-24-028839","document":"form4-12102024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924028839/form4-12102024_041201.xml","form_type":"4"}},{"id":1337390,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-10T21:30:09.000Z","date":"2024-12-06","kind":"exercise","planned":true,"acquired":true,"shares":505,"price":2.926,"value":1477.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."}],"balance_after":142455,"source":{"system":"sec-edgar","filing":"0001415889-24-028839","document":"form4-12102024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924028839/form4-12102024_041201.xml","form_type":"4"}},{"id":1379460,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-10-30T20:15:09.000Z","date":"2024-10-28","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":1396,"derivative":{"exercise_price":2.926,"expiration_date":"2027-07-14","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-24-025749","document":"form4-10302024_041006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924025749/form4-10302024_041006.xml","form_type":"4"}},{"id":1379459,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T20:15:09.000Z","date":"2024-10-28","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":3.722,"value":11166.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.70 to $3.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":141950,"source":{"system":"sec-edgar","filing":"0001415889-24-025749","document":"form4-10302024_041006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924025749/form4-10302024_041006.xml","form_type":"4"}},{"id":1379458,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T20:15:09.000Z","date":"2024-10-28","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":2.926,"value":8778.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."}],"balance_after":144950,"source":{"system":"sec-edgar","filing":"0001415889-24-025749","document":"form4-10302024_041006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924025749/form4-10302024_041006.xml","form_type":"4"}},{"id":1397979,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-30T20:15:07.000Z","date":"2024-09-26","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":4396,"derivative":{"exercise_price":2.926,"expiration_date":"2027-07-14","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-24-024090","document":"form4-09302024_040901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924024090/form4-09302024_040901.xml","form_type":"4"}},{"id":1397978,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-30T20:15:07.000Z","date":"2024-09-26","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":3.82,"value":11460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.80 to $3.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":141950,"source":{"system":"sec-edgar","filing":"0001415889-24-024090","document":"form4-09302024_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924024090/form4-09302024_040901.xml","form_type":"4"}},{"id":1397977,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-30T20:15:07.000Z","date":"2024-09-26","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":2.926,"value":8778.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."}],"balance_after":144950,"source":{"system":"sec-edgar","filing":"0001415889-24-024090","document":"form4-09302024_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924024090/form4-09302024_040901.xml","form_type":"4"}},{"id":1421016,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-28T20:30:09.000Z","date":"2024-08-26","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":7396,"derivative":{"exercise_price":2.926,"expiration_date":"2027-07-14","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-24-022448","document":"form4-08282024_040806.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924022448/form4-08282024_040806.xml","form_type":"4"}},{"id":1421015,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-28T20:30:09.000Z","date":"2024-08-26","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":4.28,"value":12840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.23 to $4.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":141950,"source":{"system":"sec-edgar","filing":"0001415889-24-022448","document":"form4-08282024_040806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924022448/form4-08282024_040806.xml","form_type":"4"}},{"id":1421014,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-28T20:30:09.000Z","date":"2024-08-26","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":2.926,"value":8778.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."}],"balance_after":144950,"source":{"system":"sec-edgar","filing":"0001415889-24-022448","document":"form4-08282024_040806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924022448/form4-08282024_040806.xml","form_type":"4"}},{"id":1446409,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-30T20:39:36.000Z","date":"2024-07-26","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":10396,"derivative":{"exercise_price":2.926,"expiration_date":"2027-07-14","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-24-020343","document":"form4-07302024_080732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924020343/form4-07302024_080732.xml","form_type":"4"}},{"id":1446408,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-30T20:39:36.000Z","date":"2024-07-26","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":4.746,"value":14238.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.63 to $4.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":141950,"source":{"system":"sec-edgar","filing":"0001415889-24-020343","document":"form4-07302024_080732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924020343/form4-07302024_080732.xml","form_type":"4"}},{"id":1446407,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-30T20:39:36.000Z","date":"2024-07-26","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":2.926,"value":8778.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."}],"balance_after":144950,"source":{"system":"sec-edgar","filing":"0001415889-24-020343","document":"form4-07302024_080732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924020343/form4-07302024_080732.xml","form_type":"4"}},{"id":1466025,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-01T21:18:21.000Z","date":"2024-06-27","kind":"exercise","planned":true,"acquired":false,"shares":4956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":13396,"derivative":{"exercise_price":2.926,"expiration_date":"2027-07-14","underlying":"Common Stock","underlying_shares":4956},"source":{"system":"sec-edgar","filing":"0001415889-24-018635","document":"form4-07012024_090717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924018635/form4-07012024_090717.xml","form_type":"4"}},{"id":1466024,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-01T21:18:21.000Z","date":"2024-06-27","kind":"exercise","planned":true,"acquired":false,"shares":5044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":1121,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":5044},"source":{"system":"sec-edgar","filing":"0001415889-24-018635","document":"form4-07012024_090717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924018635/form4-07012024_090717.xml","form_type":"4"}},{"id":1466023,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-01T21:18:21.000Z","date":"2024-06-27","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":3.99,"value":39900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.93 to $4.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":141950,"source":{"system":"sec-edgar","filing":"0001415889-24-018635","document":"form4-07012024_090717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924018635/form4-07012024_090717.xml","form_type":"4"}},{"id":1466022,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-01T21:18:21.000Z","date":"2024-06-27","kind":"exercise","planned":true,"acquired":true,"shares":4956,"price":2.926,"value":14501.256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."}],"balance_after":151950,"source":{"system":"sec-edgar","filing":"0001415889-24-018635","document":"form4-07012024_090717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924018635/form4-07012024_090717.xml","form_type":"4"}},{"id":1466021,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-01T21:18:21.000Z","date":"2024-06-27","kind":"exercise","planned":true,"acquired":true,"shares":5044,"price":1.641,"value":8277.204,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023."}],"balance_after":146994,"source":{"system":"sec-edgar","filing":"0001415889-24-018635","document":"form4-07012024_090717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924018635/form4-07012024_090717.xml","form_type":"4"}},{"id":1480900,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-13T21:31:42.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":40701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":40701,"derivative":{"exercise_price":4.68,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":40701},"source":{"system":"sec-edgar","filing":"0001415889-24-016709","document":"form4-06132024_090639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924016709/form4-06132024_090639.xml","form_type":"4"}},{"id":1480899,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T21:31:42.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":21367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":141950,"source":{"system":"sec-edgar","filing":"0001415889-24-016709","document":"form4-06132024_090639.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924016709/form4-06132024_090639.xml","form_type":"4"}},{"id":1558593,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-28T20:31:05.000Z","date":"2024-03-26","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vested monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019."}],"balance_after":617,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-24-009334","document":"form4-03282024_040349.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924009334/form4-03282024_040349.xml","form_type":"4"}},{"id":1558592,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-28T20:31:05.000Z","date":"2024-03-26","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":4.405,"value":22025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.37 to $4.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120583,"source":{"system":"sec-edgar","filing":"0001415889-24-009334","document":"form4-03282024_040349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924009334/form4-03282024_040349.xml","form_type":"4"}},{"id":1558591,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-28T20:31:05.000Z","date":"2024-03-26","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":2.142,"value":10710.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":125583,"source":{"system":"sec-edgar","filing":"0001415889-24-009334","document":"form4-03282024_040349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924009334/form4-03282024_040349.xml","form_type":"4"}},{"id":1612663,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-28T21:30:19.000Z","date":"2024-02-26","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vested monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019."}],"balance_after":5617,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-24-005727","document":"form4-02282024_040201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924005727/form4-02282024_040201.xml","form_type":"4"}},{"id":1612662,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T21:30:19.000Z","date":"2024-02-26","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":4.601,"value":23005.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.51 to $4.625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120583,"source":{"system":"sec-edgar","filing":"0001415889-24-005727","document":"form4-02282024_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924005727/form4-02282024_040201.xml","form_type":"4"}},{"id":1612661,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T21:30:19.000Z","date":"2024-02-26","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":2.142,"value":10710.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":125583,"source":{"system":"sec-edgar","filing":"0001415889-24-005727","document":"form4-02282024_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924005727/form4-02282024_040201.xml","form_type":"4"}},{"id":1666753,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-30T21:30:13.000Z","date":"2024-01-26","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vested monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019."}],"balance_after":10617,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-24-001975","document":"form4-01302024_040101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924001975/form4-01302024_040101.xml","form_type":"4"}},{"id":1666752,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-30T21:30:13.000Z","date":"2024-01-26","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":5.117,"value":25585.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.04 to $5.145, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120583,"source":{"system":"sec-edgar","filing":"0001415889-24-001975","document":"form4-01302024_040101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924001975/form4-01302024_040101.xml","form_type":"4"}},{"id":1666751,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-30T21:30:13.000Z","date":"2024-01-26","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":2.142,"value":10710.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":125583,"source":{"system":"sec-edgar","filing":"0001415889-24-001975","document":"form4-01302024_040101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000141588924001975/form4-01302024_040101.xml","form_type":"4"}},{"id":1698827,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-28T21:30:21.000Z","date":"2023-12-26","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vested monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019."}],"balance_after":15617,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-23-059910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123059910/doc4.xml","form_type":"4"}},{"id":1698826,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-28T21:30:21.000Z","date":"2023-12-26","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":4.53,"value":22650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.455 to $4.585, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120583,"source":{"system":"sec-edgar","filing":"0001209191-23-059910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123059910/doc4.xml","form_type":"4"}},{"id":1698825,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-28T21:30:21.000Z","date":"2023-12-26","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":2.142,"value":10710.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":125583,"source":{"system":"sec-edgar","filing":"0001209191-23-059910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123059910/doc4.xml","form_type":"4"}},{"id":1727823,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-29T21:36:49.000Z","date":"2023-11-27","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vested monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019."}],"balance_after":20617,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-23-056908","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123056908/doc4.xml","form_type":"4"}},{"id":1727822,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-29T21:36:49.000Z","date":"2023-11-27","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":4.59,"value":22950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.52 to $4.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120583,"source":{"system":"sec-edgar","filing":"0001209191-23-056908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123056908/doc4.xml","form_type":"4"}},{"id":1727821,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-29T21:36:49.000Z","date":"2023-11-27","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":2.142,"value":10710.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":125583,"source":{"system":"sec-edgar","filing":"0001209191-23-056908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123056908/doc4.xml","form_type":"4"}},{"id":1739331,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-16T21:48:05.000Z","date":"2023-11-14","kind":"exercise","planned":true,"acquired":false,"shares":1283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vested monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019."}],"balance_after":25617,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":1283},"source":{"system":"sec-edgar","filing":"0001209191-23-055540","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123055540/doc4.xml","form_type":"4"}},{"id":1739330,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-16T21:48:05.000Z","date":"2023-11-14","kind":"exercise","planned":true,"acquired":false,"shares":8717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on February 20, 2020, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":8717},"source":{"system":"sec-edgar","filing":"0001209191-23-055540","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123055540/doc4.xml","form_type":"4"}},{"id":1739329,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-16T21:48:05.000Z","date":"2023-11-14","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":3.71,"value":37100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.70 to $3.725, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120583,"source":{"system":"sec-edgar","filing":"0001209191-23-055540","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123055540/doc4.xml","form_type":"4"}},{"id":1739328,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-16T21:48:05.000Z","date":"2023-11-14","kind":"exercise","planned":true,"acquired":true,"shares":1283,"price":2.142,"value":2748.186,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":130583,"source":{"system":"sec-edgar","filing":"0001209191-23-055540","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123055540/doc4.xml","form_type":"4"}},{"id":1739327,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-16T21:48:05.000Z","date":"2023-11-14","kind":"exercise","planned":true,"acquired":true,"shares":8717,"price":1.641,"value":14304.597,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":129300,"source":{"system":"sec-edgar","filing":"0001209191-23-055540","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123055540/doc4.xml","form_type":"4"}},{"id":1793194,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-30T21:22:15.000Z","date":"2023-08-30","kind":"exercise","planned":true,"acquired":false,"shares":2841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on February 20, 2020, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":8717,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":2841},"source":{"system":"sec-edgar","filing":"0001209191-23-047756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123047756/doc4.xml","form_type":"4"}},{"id":1793193,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-30T21:22:15.000Z","date":"2023-08-29","kind":"exercise","planned":true,"acquired":false,"shares":2059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on February 20, 2020, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":11558,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":2059},"source":{"system":"sec-edgar","filing":"0001209191-23-047756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123047756/doc4.xml","form_type":"4"}},{"id":1793192,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-30T21:22:15.000Z","date":"2023-08-28","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on February 20, 2020, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":13617,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001209191-23-047756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123047756/doc4.xml","form_type":"4"}},{"id":1793191,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-30T21:22:15.000Z","date":"2023-08-30","kind":"sale","planned":true,"acquired":false,"shares":2841,"price":3.7,"value":10511.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.70 to $3.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120583,"source":{"system":"sec-edgar","filing":"0001209191-23-047756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123047756/doc4.xml","form_type":"4"}},{"id":1793190,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-30T21:22:15.000Z","date":"2023-08-30","kind":"exercise","planned":true,"acquired":true,"shares":2841,"price":1.641,"value":4662.081,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":123424,"source":{"system":"sec-edgar","filing":"0001209191-23-047756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123047756/doc4.xml","form_type":"4"}},{"id":1793189,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-30T21:22:15.000Z","date":"2023-08-29","kind":"sale","planned":true,"acquired":false,"shares":2059,"price":3.7,"value":7618.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.70 to $3.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120583,"source":{"system":"sec-edgar","filing":"0001209191-23-047756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123047756/doc4.xml","form_type":"4"}},{"id":1793188,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-30T21:22:15.000Z","date":"2023-08-29","kind":"exercise","planned":true,"acquired":true,"shares":2059,"price":1.641,"value":3378.819,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":122642,"source":{"system":"sec-edgar","filing":"0001209191-23-047756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123047756/doc4.xml","form_type":"4"}},{"id":1793187,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-30T21:22:15.000Z","date":"2023-08-28","kind":"sale","planned":true,"acquired":false,"shares":100,"price":3.7,"value":370.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":120583,"source":{"system":"sec-edgar","filing":"0001209191-23-047756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123047756/doc4.xml","form_type":"4"}},{"id":1793186,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-30T21:22:15.000Z","date":"2023-08-28","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":1.641,"value":164.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":120683,"source":{"system":"sec-edgar","filing":"0001209191-23-047756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123047756/doc4.xml","form_type":"4"}},{"id":1821590,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-28T20:30:09.000Z","date":"2023-07-26","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on February 20, 2020, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":13717,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-23-043689","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123043689/doc4.xml","form_type":"4"}},{"id":1821589,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-28T20:30:09.000Z","date":"2023-07-26","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":4.75,"value":23750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.72 to $4.825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120583,"source":{"system":"sec-edgar","filing":"0001209191-23-043689","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123043689/doc4.xml","form_type":"4"}},{"id":1821588,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-28T20:30:09.000Z","date":"2023-07-26","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":1.641,"value":8205.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":125583,"source":{"system":"sec-edgar","filing":"0001209191-23-043689","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123043689/doc4.xml","form_type":"4"}},{"id":1842821,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-28T21:05:43.000Z","date":"2023-06-27","kind":"exercise","planned":true,"acquired":false,"shares":7471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on February 20, 2020, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":18717,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":7471},"source":{"system":"sec-edgar","filing":"0001209191-23-040058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123040058/doc4.xml","form_type":"4"}},{"id":1842820,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-28T21:05:43.000Z","date":"2023-06-26","kind":"exercise","planned":true,"acquired":false,"shares":712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on February 20, 2020, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":26188,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":712},"source":{"system":"sec-edgar","filing":"0001209191-23-040058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123040058/doc4.xml","form_type":"4"}},{"id":1842819,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-28T21:05:43.000Z","date":"2023-06-26","kind":"exercise","planned":true,"acquired":false,"shares":6817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.983,"expiration_date":"2026-06-13","underlying":"Common Stock","underlying_shares":6817},"source":{"system":"sec-edgar","filing":"0001209191-23-040058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123040058/doc4.xml","form_type":"4"}},{"id":1842818,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-28T21:05:43.000Z","date":"2023-06-27","kind":"sale","planned":true,"acquired":false,"shares":7471,"price":4.39,"value":32797.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.355 to $4.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120583,"source":{"system":"sec-edgar","filing":"0001209191-23-040058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123040058/doc4.xml","form_type":"4"}},{"id":1842817,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-28T21:05:43.000Z","date":"2023-06-27","kind":"exercise","planned":true,"acquired":true,"shares":7471,"price":1.641,"value":12259.911,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":128054,"source":{"system":"sec-edgar","filing":"0001209191-23-040058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123040058/doc4.xml","form_type":"4"}},{"id":1842816,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-28T21:05:43.000Z","date":"2023-06-26","kind":"sale","planned":true,"acquired":false,"shares":7529,"price":4.49,"value":33805.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.44 to $4.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120583,"source":{"system":"sec-edgar","filing":"0001209191-23-040058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123040058/doc4.xml","form_type":"4"}},{"id":1842815,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-28T21:05:43.000Z","date":"2023-06-26","kind":"exercise","planned":true,"acquired":true,"shares":712,"price":1.641,"value":1168.392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":128112,"source":{"system":"sec-edgar","filing":"0001209191-23-040058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123040058/doc4.xml","form_type":"4"}},{"id":1842814,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-28T21:05:43.000Z","date":"2023-06-26","kind":"exercise","planned":true,"acquired":true,"shares":6817,"price":0.983,"value":6701.111,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023."}],"balance_after":127400,"source":{"system":"sec-edgar","filing":"0001209191-23-040058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123040058/doc4.xml","form_type":"4"}},{"id":1845464,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T21:22:41.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 22, 2024, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.57,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-039455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919123039455/doc4.xml","form_type":"4"}},{"id":2210052,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-08T20:02:58.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":26900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":26900,"derivative":{"exercise_price":4.82,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":26900},"source":{"system":"sec-edgar","filing":"0001209191-22-041606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919122041606/doc4.xml","form_type":"4"}},{"id":2607162,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36389,"kind":"person","name":"Johnston John Joseph","position":1,"cik":"0001874850","reported_name":"Johnston John Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T21:16:51.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on August 9, 2022 and the remaining shares underlying the option vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":16.63,"expiration_date":"2031-08-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-050940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874850/000120919121050940/doc4.xml","form_type":"4"}}]}